Status:
COMPLETED
Evaluation of Motor-Related Beta-Activity in Relation to Naturalistic Movement in Healthy Adult Subjects
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Motor Cortex
Primary Motor Cortex
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The whole body's voluntary movements are controlled by the brain. One of the brain areas most involved in controlling these voluntary movements is the motor cortex and it is often viewed as the primar...
Eligibility Criteria
Inclusion
- For all experiments :
- Healthy male or female
- Aged 18-40 years
- Registered with the French healthcare system
- Motivated to participate in the study
- Normal or corrected vision
- Right-handed
- Adequate knowledge of French to be able to follow directions
- Subjects must have the minimal motor ability necessary to participate in the experiment
- Subjects must be able to listen and understand the study instructions
- Subjects must be able to give written informed consent before participation
- Normal hearing
Exclusion
- For all experiments :
- Subjects with characteristics incompatible with MEG/EEG and MRI :
- Claustrophobia
- Psychiatric pathology characterized including Alzheimer's disease, Parkinson's disease, multiple sclerosis (MS), or severe traumatic brain injury
- Neuropsychological disorders or cognitive impairment including schizophrenia, bipolar disorder, seizures, epilepsy, sleep disorders
- Regular use of neurodevelopment medicines (antidepressants, neuroleptics)
- Subject has a history of skin disease or skin allergies (multiple or severe)
- Subject working with metals in their professional lives
- The subject had an MRI 2 weeks prior to experiment 1
- Implanted material (any dental apparatus containing metal including or root canals or any metallic object, pacemaker, cochlear implanted in the body)
- Pregnant women or lactating women (based on self-report)
- subjects who are not able to tolerate sitting for 1 hour (the estimated length of the experiment)
- Alcohol dependence
- Subjects who, in the opinion of the investigator are not able or willing to comply with the protocol
- For experiment 1:
- \- A head size incompatible with the use of a personalized 3D head-cast or a magnetoencephalography
Key Trial Info
Start Date :
July 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 6 2025
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04727944
Start Date
July 28 2022
End Date
January 6 2025
Last Update
August 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut des Sciences Cognitives, Marc Jeannerod, UMR 5229 CNRS
Bron, France, 69500